跳至主要内容
临床试验/NCT00606658
NCT00606658已完成早期 1 期

Usefulness of Shirodhara (Oil Dripping Treatment in Ayurveda) for Insomnia - A Case Series

Southern California University of Health Sciences2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
10
试验地点
2
主要终点
Insomnia Severity Index

研究概览

简要总结

This pilot study will attempt to test the effects of this non-invasive procedure on a small sample of insomnia patients and also determine the feasibility of recruiting and retaining participants during the trial for such treatments in the United States.

详细描述

A prospective case series design will be adopted. Due to the small sample size and the preliminary nature of the study, a single case study or case series are classified under Observational Descriptive Studies. The investigators will seek local Institutional Review Board (IRB) approval. Ten volunteers who respond to the recruitment efforts will be enrolled into the study. Successful enrollment is based on strict inclusion and exclusion criteria. Brahmi oil (sesame oil processed with Bacopa monieri and other herbs) will be used to perform Shirodhara. Each participant will be treated for 40 minutes for five consecutive days. Outcome measures data will be collected at baseline, third day and fifth day and a week after the treatment is over. Additionally, demographic data will be collected at baseline as well. Participants will be asked to record any adverse events or side effects they observe during the study period.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-75 of either sex
  • Duration of insomnia at least one year
  • Willing to sign an informed consent
  • A score of minimum 14 on the Insomnia severity index

排除标准

  • Comorbidities such as Depression or any other psychological conditions that require medications
  • Currently on prescription medication for insomnia
  • Serious medical conditions such as uncontrolled hypertension, uncontrolled diabetes, or any other acute condition that disturbs sleep and requires waking up in the middle of the night
  • Participants unwilling to comply with the protocol
  • Anyone who is in litigation or receiving disability, workers' compensation benefits

结局指标

主要结局

Insomnia Severity Index

时间窗: Baseline, end of five days and end of 14 days

次要结局

  • HD-16 Quality of Life Scale(Baseline, end of 5 days and 14 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sivarama Vinjamury

Associate Professor

Southern California University of Health Sciences

研究点 (2)

Loading locations...

相似试验